Connectus Wealth’s Myriad Genetics MYGN Stock Holding History

Connectus Wealth’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-83,754	Closed	-$1.94M	–	515
2023 Q2	$1.94M	Hold	83,754	–	–	0.04%	220
2023 Q1	$1.95M	Hold	83,754	–	–	0.05%	223
2022 Q4	$1.22M	Sell	83,754 -1,000	-1%	-$18.6K	0.03%	265
2022 Q3	$1.62M	Hold	84,754	–	–	0.03%	276
2022 Q2	$1.54M	Buy	+84,754	New	+$1.76M	0.04%	221
2022 Q1	–	Sell	-84,754	Closed	-$2.34M	–	396
2021 Q4	$2.34M	Buy	+84,754	New	+$2.46M	0.09%	132

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Connectus Wealth's MYGN Position: Q3 2023 in Review

Connectus Wealth sold out of Myriad Genetics (MYGN) in Q3 2023, closing a stake of 83,754 shares — an estimated $1.94M sold.

Connectus Wealth first reported a position in MYGN in Q4 2021 and held it in 6 quarters. The position peaked at $2.34M in Q4 2021. 186 funds tracked by Wall St. Rank hold MYGN as of Q3 2023.

Connectus Wealth reported no remaining Myriad Genetics position as of Q3 2023 after selling out during the quarter.
Connectus Wealth sold 83,754 Myriad Genetics shares in Q3 2023, an estimated $1.94M.
Connectus Wealth first reported a position in Myriad Genetics in Q4 2021 and held it in 6 quarters.
Connectus Wealth's Myriad Genetics position peaked at $2.34M in Q4 2021.
186 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2023.

Based on Connectus Wealth's 13F filing for Q3 2023, filed 13 Nov 2023.